Holders — by stockHoldings — by fund
AIGH Capital Management LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001835943
$991.8M
disclosed book value
44
positions
16.5%
largest position share
Positions, as of 2026-09-30
top 44 of 44 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | SNDKSANDISK CORP | 94,000 | $163.5M | 16.5% |
| 2 | IWMISHARES TRPUT | 400,000 | $111.2M | 11.2% |
| 3 | APPSDIGITAL TURBINE INC | 6.5M | $72.7M | 7.3% |
| 4 | INTCINTEL CORP | 500,000 | $60.1M | 6.1% |
| 5 | MXLMAXLINEAR INC | 600,000 | $54.2M | 5.5% |
| 6 | SIMOSILICON MOTION TECHNOLOGY CO | 164,000 | $45.9M | 4.6% |
| 7 | ASPNASPEN AEROGELS INC | 7.2M | $39.2M | 4% |
| 8 | CLFDCLEARFIELD INC | 1.2M | $37.9M | 3.8% |
| 9 | DDD3D SYS CORP DEL | 8.1M | $29.2M | 2.9% |
| 10 | NNBRNN INC | 7.5M | $27.6M | 2.8% |
| 11 | MEIMETHODE ELECTRS INC | 2.0M | $27.3M | 2.8% |
| 12 | FENCFENNEC PHARMACEUTICALS INC | 2.5M | $26.6M | 2.7% |
| 13 | KIDSORTHOPEDIATRICS CORP | 1.2M | $26.1M | 2.6% |
| 14 | KYTXKYVERNA THERAPEUTICS INC | 3.6M | $24.8M | 2.5% |
| 15 | ASYSAMTECH SYS INC | 1.3M | $21.0M | 2.1% |
| 16 | BDSXBIODESIX INC | 686,021 | $20.5M | 2.1% |
| 17 | NYXHNYXOAH S A | 14.6M | $20.2M | 2% |
| 18 | VUZIVUZIX CORP | 6.7M | $18.8M | 1.9% |
| 19 | FOCLEDAP TMS S A | 3.5M | $15.6M | 1.6% |
| 20 | ABEOABEONA THERAPEUTICS INC | 2.9M | $15.2M | 1.5% |
| 21 | SOPHSOPHIA GENETICS SA | 1.7M | $14.2M | 1.4% |
| 22 | CEPLCAPSTONE ENERGY PLUS INC | 2.9M | $13.1M | 1.3% |
| 23 | OESXORION ENERGY SYS INC | 407,000 | $12.4M | 1.3% |
| 24 | SPRBSPRUCE BIOSCIENCES INC | 250,000 | $12.1M | 1.2% |
| 25 | VNDAVANDA PHARMACEUTICALS INC | 2.3M | $11.0M | 1.1% |
| 26 | VSTMVERASTEM INC | 1.1M | $9.0M | 0.9% |
| 27 | RNXTRENOVORX INC | 4.3M | $6.7M | 0.7% |
| 28 | PYPDPOLYPID LTD | 1.2M | $6.6M | 0.7% |
| 29 | LRMRLARIMAR THERAPEUTICS INC | 1.9M | $5.9M | 0.6% |
| 30 | PTHSPELTHOS THERAPEUTICS INC | 256,012 | $5.4M | 0.5% |
| 31 | ADCTADC THERAPEUTICS SA | 4.3M | $5.3M | 0.5% |
| 32 | TLPHTALPHERA INC | 4.3M | $5.0M | 0.5% |
| 33 | LIDRAEYE INC | 3.9M | $4.6M | 0.5% |
| 34 | NRXSNEURAXIS INC | 540,292 | $4.0M | 0.4% |
| 35 | COYACOYA THERAPEUTICS INC | 631,912 | $3.2M | 0.3% |
| 36 | IPWRIDEAL PWR INC | 780,486 | $3.1M | 0.3% |
| 37 | APYXAPYX MEDICAL CORPORATION | 1.1M | $2.8M | 0.3% |
| 38 | WATTENERGOUS CORP | 182,000 | $2.4M | 0.2% |
| 39 | ELUTELUTIA INC | 2.5M | $2.0M | 0.2% |
| 40 | BNGOBIONANO GENOMICS INC | 1.2M | $1.8M | 0.2% |
| 41 | BFRIBIOFRONTERA INC | 1.5M | $1.6M | 0.2% |
| 42 | QNRXQUOIN PHARMACEUTICALS LTD | 236,234 | $1.1M | 0.1% |
| 43 | APREAPREA THERAPEUTICS INC | 1.0M | $761,656 | 0.1% |
| 44 | CRDLCARDIOL THERAPEUTICS INC | 100,000 | $166,000 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.